Belite Bio Shares Are Trading Higher After the Company Announced LBS-007 Was Granted FDA Fast-track Designation Status for Acute Leukemia.
Belite Bio Shares Are Trading Higher After the Company Announced LBS-007 Was Granted FDA Fast-track Designation Status for Acute Leukemia.
Belite Bio股票交易上漲，因公司宣佈LBS-007藥物獲得FDA急需藥物快速通道設計狀態用於急性白血病。
Belite Bio Shares Are Trading Higher After the Company Announced LBS-007 Was Granted FDA Fast-track Designation Status for Acute Leukemia.
Belite Bio股價上漲，因公司宣佈LBS-007藥物獲得FDA急需治療急性白血病的快速通道認定。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間